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Abstract The physiological effects of many extracellular
stimuli are initiated through receptor-promoted activation
of phospholipase C and inositol lipid signaling pathways.
The historical view that phospholipase C-promoted signaling
primarily occurs through activation of heterotrimeric G pro-
teins or tyrosine kinases has expanded in recent years with
the realization that at least three different mammalian phos-
pholipase C isozymes are directly activated by members of
the Ras superfamily of GTPases. Thus, Ras, Rap, Rac,
and Rho GTPases all specifically regulate certain phospho-
lipase C isozymes, and insight into the physiological signifi-
cance of these signaling responses is beginning to accrue.
High resolution three-dimensional structures of phospholi-
pase C isozymes also are beginning to shed light on their
mechanism of activation.—Harden, T. K., S. N. Hicks, and
J. Sondek. Phospholipase C isozymes as effectors of Ras
superfamily GTPases. J. Lipid Res. 2009. S243–S248.
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Phospholipase C (PLC) isozymes hydrolyze PtdIns(4,5)
P2 to Ins(1,4,5)P3 and diacylglycerol. Discovery over two
decades ago of Ins(1,4,5)P3 as the Ca
21-mobilizing second
messenger incontrovertibly connected agonist-promoted
activation of PLC at the plasma membrane to the cellular
and physiological actions of a broad range of hormones,
neurotransmitters, growth factors, and other extracellular
stimuli (1). The significance of PLC-catalyzed alterations
in membrane PtdIns(4,5)P2 levels subsequently broadened
with the realization that activities of many cellular proteins
are regulated by binding to this inositol lipid (2).
PLC isozymes were first purified in the 1980s and their
genes cloned soon thereafter (3). This class of signaling
proteins initially included PLC-b, PLC-g, and PLC-y, but
the mammalian family has expanded in the last decade
to include PLC-y, PLC-z, and two PLC-h isozymes (4). Al-
though PLC isozymes exhibit relatively low overall homol-
ogy, each contains a conserved catalytic core (Fig. 1A). The
historically designated X and Y domains comprise the two
halves of a highly conserved catalytic triose phosphate isom-
erase (TIM) barrel flanked on the N-terminal side by a se-
ries of elongation factor (EF)-hand domains and by a C2
domain at the C terminus. With the exception of PLC-z,
all PLC isozymes contain an N-terminal pleckstrin homol-
ogy (PH) domain, which potentially binds membrane
phosphoinositides or regulatory proteins. The catalytic
core of most of the 13 mammalian PLC isozymes is elabo-
rated with unique domains that underlie the evolution of
unique modes of regulation in these signaling proteins.
Essen et al. (5) provided the first high-resolution struc-
tures and unambiguous mechanistic insight into the active
site of a PLC isozyme. The catalytic TIM barrel of PLC-y1 is
sequestered between the series of EF-hands from the
N-terminal region and the C2 domain at the C terminus.
Portions of the first two EF-hands and the X/Y-linker that
splits the catalytic TIM barrel are not visible in several crys-
tal structures, indicating their intrinsic mobility in PLC-y1.
PLC isozymes are Ca21 dependent, and the active site binds
a Ca21 ion required for hydrolysis of phosphoinositides (5).
The C2 domain of PLC-y also binds several Ca21 ions pos-
sibly to facilitate interaction with negatively charged mem-
branes (6).
Structural and kinetic analyses indicate that substrate hy-
drolysis catalyzed by mammalian PLCs proceeds through
two steps (5, 7). Diacylglycerol and a cyclic inositol inter-
mediate are produced in a phosphotransfer step that in-
volves a general acid/base catalysis. An acyclic inositol is
then produced in a phosphohydrolysis step that involves
Ca21 cofactor-mediated lowering of the PKa of the 2-hydroxyl
group of the inositol with consequential deprotonation
and nucleophilic attack on the 1-phosphate. Invariantly
conserved histidines in the active site coordinate the
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1-phosphoryl group and function as general bases in catal-
ysis: four acidic groups ligate the Ca21 cofactor; a similarly
conserved trio of lysine, serine, and arginine coordinate
the 4-phosphoryl group; and a conserved lysine binds the
5-phosphoryl group. These active-site residues initially re-
vealed in the structure of PLC-y1 are present in all mamma-
lian PLC isozymes. Moreover, the recently solved structure
of PLC-b2 revealed an active-site architecture identical to
that of PLC-y1 (8).
Receptor-promoted regulation of PLC historically has
been thought to occur by one of two major signaling mech-
anisms (4, 9, 10). In the first case, hormones and neuro-
transmitters stimulate G-protein-coupled receptors (GPCRs)
that in turn activate ubiquitously expressed members of
the Gq subfamily of heterotrimeric G proteins. All four
PLC-b isozymes are directly activated by Ga-subunits of
the Gq subfamily. Activation of GPCRs that couple to other
G proteins (e.g., Gi) also can promote inositol lipid signal-
ing since certain of the PLC-b isozymes (PLC-b2 and PLC-
b3) are directly activated by Gbg dimers released from
heterotrimeric G proteins. The molecular basis for activa-
tion of PLC-b isozymes by Ga- and Gbg-subunits remains
undefined. However, these isozymes contain an extended
C-terminal domain that is necessary for membrane associa-
tion, Gaq-dependent activation, and promotion of the
GTPase activity of Gaq and related a-subunits. Gbg has
been proposed to interact with both the PH domain and
catalytic core of PLC-b2 and PLC-b3.
Polypeptide growth factors promote inositol lipid signal-
ing through a second major mechanism involving receptor
autophosphorylation and generation of phosphotyrosine
binding sites for PLC-g isozymes on the activated receptor
(10). Tyrosine kinase receptor-mediated phosphorylation
of PLC-g then occurs on several tyrosines, at least one of
which is critical for PLC-g activation. Receptors for anti-
gens and IgE are not tyrosine kinases, but their activation
results in activation of nonreceptor tyrosine kinases, such
as Src, that also phosphorylate PLC-g isozymes on these
tyrosines. Two SH2 domains, a single SH3 domain, and a
split PH domain are inserted between the X and Y domains
of the catalytic TIM barrel of PLC-g1 and PLC-g2. Phosphor-
ylation of Tyr-783 (and possibly Tyr-771) plays an obligatory
role in activation of PLC-g1 (11), although delineation of
the molecular details of this key step remains elusive.
Although the roles of heterotrimeric G proteins and ty-
rosine kinases in regulation of inositol lipid signaling are
broad and well established, the existence of 13 mammalian
PLC isozymes divided into six structural subclasses suggests
greater complexity in receptor-regulated PLC-dependent
signaling than initially envisioned. Below, we focus on re-
cent studies that have revealed a remarkably diverse regu-
lation of inositol lipid signaling through small GTPases of
the Ras superfamily.
REGULATION OF PHOSPHOLIPASE C BY Ras GTPases
The Ras superfamily of small GTPases comprises .150
members (12). These molecular switches fulfill critical
roles in human physiology and disease, including regula-
tion of cell proliferation, differentiation, survival, polarity,
shape, and movement, as well as regulation of gene expres-
sion, vesicle transport, and many other activities. Legions
of upstream activators and regulators of Ras GTPases exist,
and many different proteins are downstream effectors of
activated GTP-bound forms of these GTPases. Although
signaling through Ras superfamily GTPases often necessar-
ily focuses on a single GTPase in a single pathway, the exis-
tence of multiple upstream inputs and downstream outputs
as well as extensive crosstalk among pathways involving
Fig. 1. Domain architecture of PLCs and their con-
trol by Ras superfamily GTPase. Domain architecture
is drawn to scale for representative members of each
class of PLC isozyme (A), and major sites of interac-
tion between GTPases and PLCs are indicated (B).
Individual domains are discussed in the main text ex-
cept for a cysteine-rich region (C) at the N terminus
of PLC-y and a serine- and proline-rich region (S/P)
at the C terminus of PLC-h.
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these GTPases results in remarkably complex signaling
networks. Many GPCR-initiated events also activate Ras
superfamily GTPases further increasing crosstalk. For ex-
ample, GTP-bound forms of Ga12/13 and Gaq directly ac-
tivate specific GEFs, e.g., p115-RhoGEF and p63 RhoGEF,
that subsequently activate Rho GTPases (13). Similarly, active
heterotrimeric G proteins lead to the activation of Ca21/
diacylglycerol- or cyclic AMP-activated Ras/Rap GEFs, e.g.,
Epac (14).
The elegant work of Illenberger and Gierschik and their
colleagues (15, 16) first convincingly implicated a role for
small GTPases in inositol lipid signaling, and we now real-
ize that at least three different PLC isozymes (PLC-b2, -g2,
and -y) are robustly activated by Ras superfamily GTPases
(4). This regulation occurs through specific recognition of
Ras, Rap, or Rho GTPases by at least four different binding
interfaces (Fig. 1B). Thus, scores of inputs into inositol lipid
signaling potentially exist in addition to those historically
understood to be mediated by heterotrimeric G proteins
and tyrosine kinases. Since Ras superfamily GTPases exhibit
remarkable differences in subcellular localization, selective
activation of PLC isozymes occurs in various subcellular com-
partments. Certain PLC isozymes function as signaling nodes
receiving activating input from both heterotrimeric and Ras
superfamily GTPases, and at least in the case of PLC-y, this
upstream regulation results in the subsequent, direct activa-
tion of additional Ras GTPases. Knowledge of the signaling
consequences and physiological significance of small
GTPase activated PLCs continues to expand and evolve.
Rac-MEDIATED ACTIVATION OF PLC-b2
Direct activation of a PLC isozyme by a small GTPase was
first described by Illenberger, Gierschik, and colleagues
(15, 16), who showed that PLC-b2 could be purified from
cytosol of neutrophils in a GTPgS-dependent complex
with a Rho-family GTPase. Guanine nucleotide-dependent
activation of purified PLC-b2 was observed with recombi-
nant Rac1, Rac2, and Cdc42, although Cdc42 was the least
potent and efficacious of these GTPases. By contrast, RhoA
was inactive. This regulatory effect apparently is limited to
PLC-b2 because only weak Rac-promoted activation was ob-
served with PLC-b3, and no effect was observed with PLC-b1.
Snyder et al. (17) reached similar conclusions in studies
of protein-protein interactions quantified using surface
plasmon resonance. Thus, Rac1, Rac2, and Rac3, but not
Cdc42, Ras, Rho, or Rap, bound PLC-b2 with high affinity
and in a GTP-dependent fashion. PLC-b3 also bound Rac
but with lower affinity relative to PLC-b2, and no binding
occurred with PLC-b1. This specificity of GTP-dependent
binding of GTPases was entirely recapitulated with the PH
domain of PLC- b2 but not the PH domain of G protein
receptor kinase2. Evidence of binding of Rac to the PH do-
main of PLC-b2 also was obtained by Illenberger et al. (18,
19), who illustrated in studies of a series of chimeras of
PLC-b2 and PLC-b1 that Rac-dependent increases in mem-
brane association and phospholipase activity required the
presence of the PH domain from PLC-b2. As discussed be-
low, a high-resolution crystallographic structure of a GTP-
dependent complex of Rac1 and PLC-b2 unambiguously
confirmed that the GTPase/PLC-b2 interface is entirely ac-
counted for by interaction of Rac with the PH domain (8).
Ras-MEDIATED ACTIVATION OF PLC-y
Kataoka and his colleagues discovered PLC-y as a Ras
binding protein in Caenorhabditis elegans in 1998 (20), and
molecular cloning of the mammalian homolog of this iso-
zyme revealed the first PLC with conserved Ras binding do-
mains (21–23). Although the first of two Ras-associating
(RA) domains in the C terminus was reported to be the
Ras-targeted domain of the C. elegans enzyme (20), multiple
lines of evidence, including structural analyses (24), estab-
lish that the second C-terminal RA domain, RA2, is pri-
marily responsible for Ras binding to mammalian PLC-y
(Fig. 1). Mutation of two adjoining lysines (K2150 and
K2152) in RA2 of mouse PLC-y resulted in loss of GTP-
dependent binding of H-Ras, and this mutant PLC-y was
no longer activated after coexpression with H-Ras in
COS-7 cells (21). The specificity of interaction of Ras sub-
family GTPases with PLC-y has not been fully studied, but
H-Ras, K-Ras, M-Ras, Rap1A, Rap1B, and Rap2B all appear
to be activators (21, 23, 25, 26).
Although research to date largely has focused on PLC-y
as a downstream effector of Ras superfamily GTPases, this
novel PLC isozyme contains an N-terminal CDC25 GEF
domain that confers function to this protein as an up-
stream activator of small GTPases (22, 23, 25). Neither
the GTPase selectivity nor the physiological significance
of this conserved domain has been fully established. How-
ever, several studies suggested that i) PLC-y activates both
Ras and Rap GTPases; ii) activity of the GEF domain may
be important for subcellular localization of the isozyme;
iii) feed-forward activation of GTPases that interact with
the C-terminal RA2 domain may impart unique kinetics
of activation to this PLC isoform; and iv) physiological
effects of this isozyme may concomitantly involve its lipase
and GEF activities (4, 27).
Growth-factor-mediated activation of a variety of trans-
membrane receptor tyrosine kinases results in activation
of the PLC-y by a mechanism that requires the RA2 domain
(26, 28). GPCR-dependent activation of PLC-y also occurs
through cyclic AMP-dependent activation of the GEF, Epac,
which activates Rap2B (29).
Targeted disruption of PLC-y has begun to reveal biolog-
ical functions that involve regulation of PLC-y by small
GTPases. For example, studies of PLC-y-null mice revealed
an importance of this isozyme in cardiac development and
function (30, 31). Oestreich et al. (32) recently illustrated
that the physiological regulation of Ca21-induced Ca21
release in cardiac myocytes by catecholamine-activated
b-adrenergic receptors involves cyclic AMP-dependent ac-
tivation of Epac resulting in activation of Rap. Rap-activated
PLC-y then promotes diacyglycerol/Ca21-dependent acti-
vation of a protein kinase C and release of Ca21 from the
sarcoplasmic reticulum.
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PLC-y-deficient mice are resistant to skin tumor forma-
tion in a chemical carcinogen-induced model (33), and
several lines of evidence suggest that PLC-y increases tu-
mor formation by augmenting inflammatory responses in
dermal fibroblasts (34). Although the involved signaling
pathways have not been unambiguously elucidated, PLC-y
apparently functions downstream of activation of a cal-
modulin/diacylglycerol-regulated RasGEF and Rap1.
Rho-MEDIATED ACTIVATION OF PLC-y
Wing et al. (35) demonstrated that coexpression of PLC-y
with GTPase-deficient RhoA, RhoB, or RhoC, but not Rac
or Cdc42, resulted in marked elevation of intracellular
inositol phosphate accumulation. In contrast with the
effect of Ras, truncated forms of PLC-y lacking the C-
terminal RA domains retained capacity to be activated by
Rho. Studies with purified proteins have confirmed that
PLC-y is a direct effector of GTP-bound Rho through a
mechanism entirely independent of the RA domains (36).
Indeed, dual and partially synergistic activation of PLC-y
occurs in the combined presence of activated Rho and
Ras (37).
Early studies of mammalian PLC-y revealed that expres-
sion of Ga12 and Ga13, but not other heterotrimeric G pro-
tein a-subunits, resulted in PLC-y-dependent increases in
inositol phosphate accumulation (22, 38). Certain RhoGEFs,
e.g., p115-RhoGEF and LARG, are effectors of Ga12 and
Ga13 (13), and subsequent work has shown that activa-
tion of PLC-y by Ga12 and Ga13 occurs through RhoGEF-
mediated activation of Rho. Similarly, activators, e.g.,
thrombin or lysophosphatidic, of GPCRs that couple to
Ga12 and Ga13 activate PLC-y in a Rho-dependent fash-
ion (28). Activation of natively expressed PLC-y down-
stream of thrombin or lysophosphatidic acid receptors in
rat-1 fibroblasts is much more sustained than is the con-
comitant activation of PLC-b3 (39).
Studies of astrocytes isolated from wild-type and PLC-
y-deficient mice illustrated that inositol lipid signaling
responses to thrombin, sphingosine 1-phosphate, and lyso-
phosphatidic acid occur through mechanisms involving
activation of PLC-y (40). The lysophosphatidic acid and
sphingosine-1P-promoted effects depend on activation of
Gi-coupled GPCRs and presumably release of Gbg. By con-
trast, the effects of thrombin on PLC-y occur through acti-
vation of Rho. PLC-y also is required for the stimulatory
effects of thrombin on ERK phosphorylation and DNA syn-
thesis, and PLC-y is both a downstream effector and up-
stream activator of small GTPases in this cell proliferative
response. That is, thrombin-promoted proliferative effects de-
pend on Rho-promoted coupling to PLC-y, which promotes
activation of Rap via the CDC25 GEF domain of PLC-y.
Rac-MEDIATED ACTIVATION OF PLC-g2
Gierschik and his colleagues also discovered that coex-
pression of PLC-g2 with GTPase-deficient mutants of Rac1,
Rac2, or Rac3 (but not Cdc42 or RhoA) results in marked
increases in inositol phosphate accumulation (41). No evi-
dence for activation of PLC-g1 was observed with any of
these GTPases. A similar selectivity for GTP-dependent
activation of PLC-g2 by Rac was observed in studies with ho-
mogenates from cells overexpressing these signaling pro-
teins. Since mutation of tyrosines known to be important
for phosphorylation-dependent activation of PLC-g2 had
no effect on Rac-promoted activation, this GTPase-regulated
signaling response apparently occurs independently of tyro-
sine kinase-mediated signaling.
Like all PLC isozymes, PLC-g1 and PLC-g2 contain an N-
terminal PH domain. However, they also contain a second
PH domain within the X/Y-linker that separates the halves
of the catalytic TIM barrel (Fig. 1). This PH domain is “splitʼ
in primary sequence by two SH2 domains and an SH3 do-
main forming a unique X/Y-linker. Walliser et al. (42) re-
cently investigated the basis for selective interaction of Rac
GTPases with PLC-g2 versus PLC-g1 and discovered that the
split PH domain of PLC-g2 accounts for GTP-dependent
binding of these GTPases. Mutational studies and NMR
spectroscopy revealed that the Rac binding interface resides
in b-strand 5 and the a-helix region of the split PH domain.
This interface notably differs from the Rac1 binding surface
Fig. 2. Model for the autoinhibition and general activation of PLC
isozymes. The active site (yellow) of a PLC isozyme is blocked by a
highly mobile and negatively charged X/Y-linker that also prevents
high-affinity binding of the PLC to membranes. An upstream input,
e.g., GTP-bound Rac, favors the binding of the PLC to membranes
to promote the movement of the X/Y-linker away from the active
site while simultaneously orienting the active site for optimal access
of phosphoinositide substrates.
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of the PH domain of PLC-b2, which was shown by Jezyk
et al. (8) to involve primarily b-strand 1 and loop regions
in structural proximity to this strand. The mechanism of
Rac-promoted activation of PLC-g2 remains unclear, al-
though relief of an autoinhibited state has been suggested.
The physiological significance of Rac-promoted PLC-g2-
dependent signaling also remains undefined, although both
PLC-g2 and Rac2 are involved in B lymphocyte develop-
ment and signaling (41).
MECHANISM OF GTPase-PROMOTED ACTIVATION
OF PLC ISOZYMES
Significant insight into the mechanism of activation of
PLC isozymes by Ras-family GTPases recently accrued from
high-resolution, three-dimensional structures of a GTP-
dependent complex of Rac1 and PLC-b2 and of PLC-b2
in the absence of G protein activator (8, 43). No conforma-
tional changes are induced in PLC-b2 by activated Rac1,
and the structures suggested autoinhibition of the isozyme
occurs due to occlusion of the active site by a portion of
the X/Y-linker. This linker connects the highly conserved
halves of the catalytic TIM barrel but is highly variable in
length and sequence across all 13 PLC isozymes. This re-
gion also is highly disordered, as it was not observed in
the high-resolution structure of PLC-y1, and only 20 of the
?70 residues of the X/Y-linker are observed in the two PLC-
b2 structures.
Occlusion of the active site of PLC-b2 by an ordered por-
tion of the X/Y-linker led to the hypothesis that this isozyme
exists in an autoinhibited state (Fig. 2). Consistent with this
idea, removal of the ordered portion of the X/Y-linker re-
sulted in marked increases in lipase activity (43). Indeed,
mutation of a single glycine of the X/Y-linker that makes
backbone and side chain contacts with catalytic residues
in the active site resulted in a markedly activated enzyme.
Several results suggest a still to be defined interplay between
this ordered region and the remainder of the X/Y-linker in
regulation of enzyme function. For example, removal of the
disordered region of PLC-b2 resulted in larger activation
than did removal of the ordered region, and removal of
the entire X/Y-linker of PLC-b2 resulted in even greater ac-
tivation than observed with removal of either the ordered or
disordered regions alone. Activation of PLC-b2 by Rac
GTPases requires an intact PH domain (17, 18), activation
by Gaq requires the C terminus, and activation by Gbg re-
quires the PH domain and/or sequence in the Y-box of the
catalytic TIM barrel (4, 10). The very active X/Y-linker-
deleted mutants of PLC-b2 nonetheless retain capacity to
be activated by all three G protein activators (43). These ob-
servations and the absence of Rac-induced conformational
changes in the active site of PLC-b2 indicate that G-protein-
dependent activation involves recruitment and orientation
of the isozyme at the plasma membrane. Long stretches of
acidic amino acids exist in the X/Y-linker, and these areas
of dense negative charge likely are repelled from negatively
charged membranes upon binding of PLC-b2 to membrane-
resident G protein activators. This repulsion presumably re-
moves the X/Y-linker from near the active site of PLC-b2 to
relieve autoinhibition (Fig. 2).
Whereas mammalian PLC isozymes differ in length and
sequence of their X/Y-linkers, most of these proteins pos-
sess areas of dense negative charge in this region. Moreover,
removal of the linker region of PLC-y1 or PLC-y also results
in remarkable activation of these signaling proteins (43),
strongly suggesting that a common mechanism of autoin-
hibition and activation controlled by the X/Y-linker occurs
in most if not all PLC isozymes.
CONCLUSION
PLC isozymes receive and coordinate multiple upstream
inputs, many of which involve Ras superfamily GTPases. It
will be important to more fully place these PLC-dependent
signaling nodes in the wider context of the remarkably
large set of biological responses associated with activation
of Ras family GTPases. Recent structural analyses also sug-
gest that the mechanism of activation of PLC isozymes by
Ras GTPases and by heterotrimeric G proteins or by tyro-
sine phosphorylation will soon be revealed.
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